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Nanomedicine, as defined by the NIH Roadmap 
Initiative, can be considered as an offshoot of 
nanotechnology, dealing with highly specific 
medical interventions at the molecular scale for 
curing disease or repairing damaged tissues, such 
as bone, muscle, or nerve.  Simply stated it is the 
medical application of nanotechnology. By 
controlling and modifying matter at a nanoscale, 
the physical properties of materials change 
dramatically, offering a wide variety of 
applications in the medical field including 
advanced drug delivery systems to alter the 
pharmacokinetics and biodistribution of drugs, 
improved in vivo imaging, and targeted drug 
delivery by localizing therapy to a certain region of 
the body such as tumors. 
Nanotechnology is often viewed as a relatively 
young field, with tremendous potential to reinvent 
existing therapies and significantly improve 
standards of living. Surprisingly though, the seeds 
of nanotechnology as a new frontier in medicine 
were laid centuries ago when the movement from 
macro to micro had gained momentum. The 
invention of microscope afforded opportunities to 
detect and study microorganisms such as bacteria, 
understand histopathology of healthy and diseased 
tissue, etc. Microsurgery opened avenues to carry 
our surgeries that would have been deemed risky 
and fatal on the conventional platforms. 
Nanotechnology has now laid the platform of 
understanding the cellular processes at the 
molecular level, incorporate advances in 
proteonomics and genomics to provide possibilities 
for development of technologies, therapies which 
will integrate into mainstream medicine. 
Nanotechnology will lead to the most exciting 
advances in medicine in the 21st Century. In the 
past few decades, the semiconductor manufacturing 
process, microfabrication technology has enabled 
the development of microsensors, micro-actuators, 
and various microsystems, integrating electrical, 
mechanical, optical, and fluidic components. These 
well established technologies can now provide 
tools and instruments to understand and manipulate 
the biological nano environment. 
Various nanotechnology platforms like fullerenes, 
nanotubes, quantum dots, nanopores, dendrimers, 
liposomes, magnetic nanoprobes and radio labelled 
nanoparticles are being developed or 
conceptualized to support novel medical advances.  
Nanomedicine offers an opportunity to 
significantly improve the safety and efficacy 
profiles of a drug by tissue specific drug targeting 
of the drug. Nanoscale multifunctional materials, 
capitalizing on progress in genomics and 
proteomics, allow targeted delivery of molecular 
therapies with enhanced efficacy. Development of 
newer drug delivery systems based on 
nanotechnology methods is being tried for 
conditions like cancer, diabetes, fungal infections, 
viral infections and in gene therapy. An emerging 
application of nanotechnology is in the 
understanding of disease processes. Science has 
made significant advances in the understanding of 
the biochemical basis of many disease processes 
and the underlying biochemical pathways.  In many 
instances, the genetic basis for the disease process 
is also well understood. Unfortunately, the need for 
ultra-sensitive, real-time monitoring and detection 
technologies remains. Nanotechnology can be used 
to design multi-functional and multi-analyte 
diagnostic systems that not only define early stage 
changes or progression to a disease state, but also 
allow the identification and detection of 
biomarkers, chemicals and structures that cannot be 
detected by the current assay technologies. 
The current issue of Internet Journal of Medical 
Update focuses on emerging applications of 
nanotechnology in the fields of nuclear imaging 
and cancer nanotechnology. The review article on 
Nuclear Imaging discusses how radio nuclei can be 
tagged to tissue targeted nanoparticles using 
various approaches and rendering them available 
for nuclear imaging. One major advantage of this 
approach is the potential to improve the safety the 
radio nuclei by limiting the exposure of radiation to 
specific tissue thus improving the therapeutic 
index. The next review on Cancer Nanotechnology 
discusses the application of this exciting field in the 
area of cancer research and treatment advances. Mody et al / Nanomedicine 
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The lack of effective chemotherapy mainly results 
from the non-selective delivery of the 
chemotherapy to all biological tissue, including the 
tumor. This results in significant side-effects with 
the therapy, reducing the therapeutic index and 
increasing the potential for a toxic outcome. Cancer 
nanotechnology is being perceived as an area of 
research that may be able to overcome the 
drawbacks of the conventional treatment. In 
addition to discussing the conventional approaches 
using nanoparticles and liposomes for delivery of 
chemotherapeutics, the article also reviews the 
more recent advances in this area that include use 
of arrays of nanocantilevers, nanotubes and 
nanowires for multiplexing detection, 
multifunctional injectable nanovectors for 
therapeutics and diagnostics are discussed. The 
third article discussed the fascinating area of 
ultrasonography and the application of nanoparticle 
imaging technology to improve the resolution and 
tissue differentiation using ultrasonography. The 
review article highlights how the acoustic 
properties of tissues can be modified differentially 
using contrast agents thus improving the ability to 
distinguish between tissues, allowing for improved 
image quality and resolution. 
Nanomedicine is a very promising frontier of 
science expected to deliver significant advances in 
the areas of medical diagnosis and therapeutics. 
The expectations are high and unforeseeable 
applications of nanotechnology are being 
conceived and developed. At the same time though, 
the safety of this technology is not adequately 
understood in humans. The very same properties of 
nanoparticles that offer them unique advantages 
can be related to safety concern that may arise.   
The biological effects of various nanoparticles vary 
according to physiochemical properties of the 
particle which may include size, chemical 
composition, and surface structure. The small size 
of nanoparticles subjects them to same risk as 
toxicities associated with particulate matter.  The 
toxic properties of these nanoparticles and their 
biocompatibility need to be investigated for the 
technology to be viable. Adequate evaluation of 
risk and safety will be of paramount importance for 
broad acceptance of this very exciting field. 
Nanomaterials are likely to receive closer attention 
from regulatory bodies for toxicological potential 
in a number of different applications. As the field 
matures, nanomedicine will play an important role 
in the diagnosis and treatment of human disease. It 
is a matter of time when this approach to disease 
intervention will become an integral part of modern 
medicine. 
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